364 related articles for article (PubMed ID: 29036697)
1. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
2. Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.
Eloranta S; Brånvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekström-Smedby K
Eur J Haematol; 2018 Jan; 100(1):61-68. PubMed ID: 28983970
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
Gittleman H; Cioffi G; Vecchione-Koval T; Ostrom QT; Kruchko C; Osorio DS; Finlay JL; Barnholtz-Sloan JS
J Neurooncol; 2019 Jun; 143(2):251-260. PubMed ID: 31025275
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
5. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
Truitt G; Gittleman H; Leece R; Ostrom QT; Kruchko C; Armstrong TS; Gilbert MR; Barnholtz-Sloan JS
J Neurooncol; 2019 Aug; 144(1):53-63. PubMed ID: 31209773
[TBL] [Abstract][Full Text] [Related]
6. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
7. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
9. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.
Legler JM; Ries LA; Smith MA; Warren JL; Heineman EF; Kaplan RS; Linet MS
J Natl Cancer Inst; 1999 Aug; 91(16):1382-90. PubMed ID: 10451443
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P; Shiels MS; Lynch CF; Engels EA
Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
[TBL] [Abstract][Full Text] [Related]
13. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
15. Brain and other central nervous system tumor statistics, 2021.
Miller KD; Ostrom QT; Kruchko C; Patil N; Tihan T; Cioffi G; Fuchs HE; Waite KA; Jemal A; Siegel RL; Barnholtz-Sloan JS
CA Cancer J Clin; 2021 Sep; 71(5):381-406. PubMed ID: 34427324
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
Khanna V; Achey RL; Ostrom QT; Block-Beach H; Kruchko C; Barnholtz-Sloan JS; de Blank PM
J Neurooncol; 2017 Dec; 135(3):433-441. PubMed ID: 28828582
[TBL] [Abstract][Full Text] [Related]
17. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years.
Shibamoto Y; Tsuchida E; Seki K; Oya N; Hasegawa M; Toda Y; Takemoto M; Sumi M; Hiratsuka J; Oguchi M; Hosono M; Yasuda S; Sougawa M; Kakutoh Y; Hayabuchi N
J Cancer Res Clin Oncol; 2004 Jun; 130(6):351-6. PubMed ID: 15034788
[TBL] [Abstract][Full Text] [Related]
19. Survival among patients with primary central nervous system lymphoma, 1973-2004.
Norden AD; Drappatz J; Wen PY; Claus EB
J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
[TBL] [Abstract][Full Text] [Related]
20. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]